For Immediate Release
Chicago, IL – November 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include DXP Enterprises Inc. DXPE, Bristol-Myers Squibb Co. BMY, EnPro Industries Inc. NPO, Illumina Inc. ILMN and NetApp Inc. (NTAP).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Thursday’s Analyst Blog:
Wall Street Likely to Sustain Post-Midterm Rally: Top Picks
Following a jolt in October, Wall Street has been in recovery mode since the beginning of November. This recovery gained a boost on Nov 7, as U.S. stocks rallied following the declaration of midterm Congressional election results. In fact, investors’ optimism has been revived on risky assets like equities with a divided U.S. Congress where Republicans have strengthened hold on the Senate while Democrats regained control of the House of Representatives after eight years.
Wall Street bull run is likely to continue in the rest of 2018 as holiday sales season is approaching. Consequently, it will be prudent to invest in stocks from industries like infrastructure, construction, healthcare and technologies with a favorable Zacks Rank.
Is Divided Congress Good for Investors?
Some analysts are also optimistic about Trump’s earlier comment that he is willing to co-operate with Democrats for some of the core Democratic issues like price control on pharmaceuticals, increased spending on infrastructure projects and middle-class tax cut. Democrats are also likely to co-operate with Trump administration regarding higher defense spending on 2019.
However, much will depend on Trump’s attitude as he already warned Democrats of a “warlike situation" if they choose to launch investigations into his administration.
Investors Welcome Midterm Election Results
On Nov 7, all three major stock indexes rallied as the picture of a divided U.S. Congress became clear. The Dow jumped 545.29 points or 2.1% to 26,180.30. The S&P 500 soared 58.44 points or 2.1% to 2,813.89. Meanwhile, Nasdaq Composite surged 194.79 points or 2.6% to 7.570.75.
Notably, Wednesday marked biggest single-day climb for both the Dow and Nasdaq since Oct 16, while the S&P 500 recorded its biggest single-day gain since Oct 25. Moreover, the Dow and S&P 500 posted their largest after mid-term election gain since 1982.
Bull Run Likely to Continue
The Wall Street bull-run is likely to continue buoyed by a strong U.S. economy. The U.S. GDP’s increased 3.3% in the first nine months of 2018, surpassing the target of 3% set by President Trump.
The U.S. consumer confidence index for October was pegged at 137.9, the highest reading since September 2000. The future expectations index — reflecting what Americans think the economy will look like in the next six months — increased to 114.6 from 112.5, signaling strong growth at least up to first quarter of 2019.
Moreover, The National Retail Federation projected that holiday retail sales (excluding automobiles, gasoline and restaurants), will jump between 4.3% to 4.8% this year. Total sales could climb as high as $720.89 billion.
Our Top Picks
At this stage, investment in stocks of infrastructure, construction, healthcare and technologies industries will be lucrative. We have narrowed our search on five such stocks with a Zacks Rank #1 (Strong Buy) and strong growth potential. You can see the complete list of today’s Zacks #1 Rank stocks here.
DXP Enterprises Inc. engages in distributing maintenance, repair, and operating products, equipment, and services to energy and industrial customers in the United States. The company has expected earnings growth of 97.7% for current year. The Zacks Consensus Estimate for the current year has improved by 13.3% over the last 30 days.
Bristol-Myers Squibb Co. discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company has expected earnings growth of 27.6% for current year. The Zacks Consensus Estimate for the current year has improved by 5.8% over the last 30 days.
EnPro Industries Inc. is a diversified manufacturer of proprietary engineered products used in critical applications. The company has expected earnings growth of 62.6% for current year. The Zacks Consensus Estimate for the current year has improved by 5.9% over the last 30 days.
Illumina Inc. is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. The company has expected earnings growth of 43% for current year. The Zacks Consensus Estimate for the current year has improved by 4.8% over the last 30 days.
NetApp Inc. provides software, systems, and services to manage and share date on-premises, and private and public clouds worldwide. The company has expected earnings growth of 27.7% for current year. The Zacks Consensus Estimate for the current year has improved by 1.6% over the last 30 days.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report
EnPro Industries (NPO) : Free Stock Analysis Report
DXP Enterprises, Inc. (DXPE) : Free Stock Analysis Report
Illumina, Inc. (ILMN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research